Eplerenone effectively treats hypertension and aldosterone-induced damage in CV organs Nov. 9, 1998 No Comments
Novel endothelin antagonists claimed for cardiovascular, cerebrovascular and other disorders Nov. 6, 1998 No Comments
Ribozyme oligonucleotides against apo(a) as novel therapeutic strategy for cardiovascular diseases Nov. 5, 1998 No Comments
Optimal dosing regimen for 5G1.1-SC in heart attack under evaluation in phase I trial Nov. 4, 1998 No Comments
RSS